Navigation Links
New Data on the GlycoMark® Test In Patients Taking SGLT-2 Inhibitors To Be Presented at the American Diabetes Association 79th Scientific Sessions
Date:6/4/2019

GlycoMark, Inc. announces new data on the GlycoMark® test in patients on SGLT-2 inhibitors are being presented June 8 – 10 at the American Diabetes Association (ADA) Scientific Sessions 2019 in San Francisco. The GlycoMark test, an FDA-cleared and CE-marked blood test used to monitor glycemic control in patients with diabetes, is uniquely sensitive and specific to detecting high blood glucose levels and glucose variability occurring during the prior 1 to 2 weeks. A low (abnormal) GlycoMark result indicates poor glucose control including postprandial glucose variability, which can be missed in up to 40% of patients with a “good” A1C.(1) The new study “GlycoMark 1,5-Anhydroglucitol Values in Patients Taking SGLT-2 Inhibitors” will be on display in the Clinical Therapeutics/New Technology–SGLT Inhibitors poster sessions Hall F, North, Exhibition Level, June 8 - 10, and attended by GlycoMark Clinical Affairs and study co-author on Sunday, June 9 from 12 - 1 p.m. For interviews or to schedule a meeting with GlycoMark during the ADA Scientific Sessions, please email GlycoMark@L3Healthcare.com.

The GlycoMark Test has not been FDA cleared for monitoring SGLT-2 inhibitor effect. The GlycoMark test is for professional use, and is indicated for the intermediate term monitoring of glycemic control in people with diabetes.

Reference: 1. Erlinger TP, Brancati FL. Diabetes Care. 2001 Oct;24(10):1734-8.

About GlycoMark, Inc.

GlycoMark, Inc., based in Manhattan, New York, is dedicated to improving the management and health of patients with diabetes. The company is a joint venture among Toyota Tsusho America, Inc. (New York, NY), Toyota Tsusho Corporation (Tokyo, Japan), and Nippon Kayaku Co., Ltd. (Tokyo, Japan), and is the exclusive supplier of the GlycoMark test in the U.S., Europe, Australia, the Asia-Pacific Region and the Middle East. The GlycoMark test is an FDA-cleared, non-fasting blood test that detects hyperglycemia and hyperglycemic excursions occurring in the prior 1 to 2 weeks. Since its discovery, the GlycoMark test, a quantitative test for 1,5-Anhydroglucitol (1,5-AG), has been described in more than 1,300 scientific and medical publications and is shown to be independently associated with complications of diabetes. More information is available at http://www.GlycoMark.com.

GlycoMark, Inc. is the exclusive licensee of the GlycoMark test, trademark and logo.

Read the full story at https://www.prweb.com/releases/new_data_on_the_glycomark_test_in_patients_taking_sglt_2_inhibitors_to_be_presented_at_the_american_diabetes_association_79th_scientific_sessions/prweb16353197.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine news :

1. Glycomark®, Inc. Partners With Shiel Medical Laboratory To Expand Glycomark Test In The Northeast
2. AdventHealth Ocala to Provide Specialized Care to the Youngest Patients on New Pediatric Unit
3. Delta Hospital Employs Telehealth & Remote Patient Monitoring to Extend Care to Rural Patients
4. AdventHealth Delivers on Promise to Keep Patients Safe at Hospitals
5. House Calls May be the Answer for Patients Concerned about Measles and Other Illnesses, says Dr. Michael Farzam of House Call Doctor Los Angeles
6. Patients Today Are Asking - Which Doctors Are on Top?
7. Women's Excellence Interviews Patients on Infertility and Robotic Surgery
8. Dr. Shervin Naderi Awarded the 2019 Patients’ Choice Award
9. Allegheny Health Network Receives $5 Million Federal Grant to Evaluate Enhanced Screening, Intervention in Primary Care Settings for Patients with Substance Use Disorders
10. The LESS Institute and Dr. Kingsley R. Chin Support Patients After Laser Spine Institute Closes
11. Dental Care Alliance Announces New Affiliation Focused on Midland Park, New Jersey’s Youngest Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2019)... , ... September 18, 2019 , ... DOROT hosts its annual Rosh Hashanah Package delivery ... more than 700 volunteers will be heading out to visit our seniors. , ... The Upper East Side, at Central Synagogue 123 East 55st Street , ...
(Date:9/18/2019)... ... September 18, 2019 , ... A new study by BestPlaces looks at ten indicators to ... the only Federally-mandated right, so other related rights vary widely across the 50 states. ... change an individual's sexual orientation) , Employment , Education , ...
(Date:9/18/2019)... , ... September 18, 2019 , ... ... for the fourth consecutive year. Dr. Scagnelli specializes in general and cosmetic dentistry ... in the 1940’s and has been delivering quality dental care over the past ...
(Date:9/17/2019)... ... September 17, 2019 , ... Milwaukee-area dealership Hall Cars has hosted an annual event each fall ... event, entitled “Drive Out Cancer,” entails that for every vehicle purchased from Sept. 17 to ... event lasts for 50 days, it has also been referred to as, “50 for 50.” ...
(Date:9/17/2019)... ... September 17, 2019 , ... ... Keflezighi and the American Heart Association (AHA)-San Diego Chapter to raise awareness of ... Stroke Walk on Saturday, September 21 in Balboa Park alongside National University System ...
Breaking Medicine News(10 mins):
(Date:9/18/2019)... ... September 18, 2019 , ... The ... training standards for eating disorder healthcare professionals, announces scholarship offerings for its 34th ... at ChampionsGate in Orlando. Intended for first-time attendees, the financial aid scholarships cover ...
(Date:9/18/2019)... ... 2019 , ... Lake Minnetonka Orthodontics, with locations in Minnetonka, ... Hybrid-Responsive™ website: https://www.lakeminnetonkaortho.com . , The staff of Lake Minnetonka Orthodontics ... with the practice more easily online. Improvements include increased usability, online scheduling, and ...
(Date:9/18/2019)... ... September 18, 2019 , ... Henry Ford e-Home Care has ... Henry Ford’s e-Home Care program. Achieving monthly readmission rates as low as 7%, ... first six months of 2019 by 45% compared with the prior six months ...
Breaking Medicine Technology: